Breaking News, Financial News

Financial Report: PAREXEL

Revenues up 25% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PAREXEL 2Q Revenues: $483.1 million (+25%) 2Q Earnings: $21.3 million (+65%) YTD Revenues: $945.7 million (+26%) YTD Earnings: $36.4 million (+62%) Comments: Clinical Research Services (CRS) revenue was $320.6 million in the quarter, up 29%. PAREXEL Consulting & Medical Communications Services (PCMS) revenues were $49.3 million, up 28%. Perceptive Informatics (PI) revenues were $101.4 million, up 12%. Newly-acquired Liquent, Inc. contributed $0.4 million to revenue in the quarter. Backl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters